XT8-29493-52072
3 vaccinations
5 coded responses
37 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 532 / WI
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
-
2021-02-02
Dose 2 — Pfizer-BioNTech
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-04
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: FairFree text: enlarged axillary lymph nodes on injection sideMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-04
- 2021-08-03
-
2021-11-21
Dose 3 — Pfizer-BioNTech
- 2021-11-21
-
2021-11-22
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-11-23
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: PainFree text: Axillary lymph node swollen on injection sideMedDRA releases: 2024-11 · check-in free text available
-
2021-11-24
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Swollen axillary lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2021-11-26
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen axillary lymph nodesMedDRA releases: 2024-11 · check-in free text available
- 2021-11-28
- 2021-12-05
- 2021-12-12
- 2021-12-19
- 2021-12-26
- 2022-01-02
- 2022-02-20
- 2022-05-24
- 2022-11-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-11-21 | Pfizer-BioNTech | No |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): enlarged axillary lymph nodes on injection side
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat
Systemic reaction (other): Axillary lymph node swollen on injection side
Systemic reaction (other): Swollen axillary lymph nodes
Systemic reaction (other): Swollen axillary lymph nodes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release